Design and Evaluation for Equity Core
股权核心设计与评估
基本信息
- 批准号:10693142
- 负责人:
- 金额:$ 11.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-16 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressApplications GrantsBlood VesselsCardiologyCaringClinicalClinical MedicineCollaborationsCommunitiesComplementConsultationsDataData AnalyticsData SetDatabasesDecision MakingDetectionDiabetes MellitusDiabetes preventionDiagnosisDiscipline of NursingDisparity populationDissemination and ImplementationEconomicsEffectivenessEndocrinologyEngineeringEpidemiologyEquityEthicsEvaluationEventEvidence based interventionFamiliarityFederal GovernmentFundingGeographic LocationsGeriatricsGoalsGrantGuidelinesHealthHealth Disparities ResearchHealth ServicesHealth Services ResearchHealth systemHealthcareIncidenceInfrastructureInstitutionInternshipsInterventionInvestmentsJournalsK-Series Research Career ProgramsLifeLinkLocal GovernmentManuscriptsMedicineMentorsMetabolicMethodologyMethodsMinorityMorbidity - disease rateOutcomePathway interactionsPersonsPilot ProjectsPlayPoliciesPolicy ResearchPopulationPopulation HeterogeneityPopulations at RiskPreventionPrevention programPreventivePreventive servicePrimary CareProceduresPublishingQuality of CareRecommendationReportingResearchResearch DesignResearch PersonnelResourcesRoleScienceServicesSeverity of illnessStructureStudentsSurveysSystemTarget PopulationsTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUniversitiesVariantburden of illnesscare costscatalystcomorbiditycomparative effectivenesscost effectivecost effectivenessdesigndiabetes managementdiabetes riskdisparity eliminationdisparity gapexperiencegaps in accessgeographic disparityhealth care service utilizationhealth disparityhealth equityhealth recordimplementation effortsimplementation frameworkimplementation scienceimprovedimproved outcomeinnovationlearning progressionminority investigatormulti-component interventionmultidisciplinarypatient orientedpersonalized approachpopulation basedpragmatic trialpreventprogramsprovider behaviorsocial determinantsstatisticssuccesssymposiumtooltraining opportunitytranslational potentialtranslational scientistuptake
项目摘要
CORE B: PROGRAM SUMMARY / ABSTRACT
While there has been much progress in building the evidence to prevent diabetes and its complications, and
notable improvements in quality of care and incidence of vascular complications among people with diagnosed
diabetes over the past 30 years, there is a large unfinished agenda. Identification of people at risk for and with
diabetes, and uptake of prevention programs are suboptimal; and more can be done to achieve recommended
care goals and reduce morbidity, especially among minorities and vulnerable subpopulations. Translation
research, especially health and preventive services research, design, and evaluation can help close gaps
equitably by helping identify how to tailor implementation efforts to better suit target populations and by
generating policy-, program-, and practice-oriented data to inform investments in diabetes. Though there is
plentiful demand in the Southeastern U.S., availability of relevant expertise is limited and fragmented, which is
a barrier for aspiring junior and underrepresented minority (URM) investigators. Core B (Design and
Evaluation for Equity) of the Georgia Center for Diabetes Translation Research (GCDTR) is poised to fill this
void by facilitating access to local, regional, and national datasets (Aim 1); offering accessible, cohesive, and
multi-disciplinary methodological, analytical, and strategic expertise in diabetes translation research (Aim 2);
and helping link research with opportunities for translation and implementation (Aim 3). Core B's collective
expertise, networks and partnerships, and access to key databases that are in high demand make it well-suited
for stimulating high-quality diabetes translation research and uptake among a wide array of stakeholders
(academics, health care, non- and for-profit organizations, and local and federal government). In its first 4
years, Core B has developed a strong culture of multi-disciplinarity, collegiality, continuous learning, and
leverage. Building on these successes, Core B will continue its focus on prioritizing support for junior and URM
investigators. The Core is well-integrated with other GCDTR Cores and Programs and embodies the same
ethos of promoting equity at our institutions, our membership, and in our research. Core Experts will continue
to engage in the GCDTR's catalyst and dissemination activities (Pilot and Feasibility and Enrichment
Programs) and complement the other Cores. Core B Experts will be accessible and active with simple
operating and reporting structures that facilitate more effective and cost-effective science. Core B has
expertise in health services and disparities research, clinical medicine (primary care, geriatrics, endocrinology,
preventive cardiology), nursing, systems design, statistics, analytics, epidemiology, engineering, management,
and economics. Continuing to leverage Core B's collective expertise and resources offers an expedient and
efficient opportunity to advance the field, promoting equity for the increasingly diverse population in the
Southeastern U.S., and informing local initiatives to improve metabolic health in the region.
核心B:数据摘要/摘要
虽然在建立预防糖尿病及其并发症的证据方面取得了很大进展,
在诊断为糖尿病的患者中,护理质量和血管并发症的发生率显著改善
在过去的30年里,糖尿病有一个很大的未完成的议程。确定有感染和感染艾滋病毒风险的人
糖尿病和预防计划的吸收是次优的;可以做更多的工作来实现推荐的目标。
(b)确保实现保健目标和降低发病率,特别是在少数群体和弱势亚群体中。翻译
研究,特别是卫生和预防服务的研究、设计和评估有助于缩小差距
帮助确定如何使执行工作更适合目标人群,
生成政策,计划和实践导向的数据,为糖尿病投资提供信息。虽然有
美国东南部需求旺盛,相关专门知识的可用性有限且分散,
有抱负的初级和代表性不足的少数民族(URM)研究人员的障碍。核心B(设计和
格鲁吉亚糖尿病转化研究中心(GCDTR)的公平性评估)正准备填补这一空白。
通过促进对本地、区域和国家数据集的访问(目标1)而无效;提供可访问、有凝聚力且
糖尿病翻译研究的多学科方法,分析和战略专业知识(目标2);
并帮助将研究与翻译和实施的机会联系起来(目标3)。核心B的集体
专门知识、网络和伙伴关系以及能够进入需求量很大的关键数据库,使其非常适合
促进高质量的糖尿病翻译研究和广泛的利益相关者之间的吸收
(学术界、医疗保健、非营利和营利组织以及地方和联邦政府)。在其第一个4
多年来,核心B已经形成了一种强大的多学科文化,合议,不断学习,
杠杆在这些成功的基础上,核心B将继续重点优先支持初级和统一资源管理
investigators.核心与其他GCDTR核心和程序集成良好,并体现了相同的
在我们的机构,我们的会员和我们的研究中促进公平的精神。核心专家将继续
参与GCDTR的催化剂和传播活动(试点、可行性和充实
程序),并补充其他核心。核心B专家将通过简单的
运作和报告结构,以促进更有效和更具成本效益的科学。核心B具有
卫生服务和差距研究,临床医学(初级保健,老年病学,内分泌学,
预防心脏病学),护理,系统设计,统计,分析,流行病学,工程,管理,
和经济学。继续利用核心B的集体专业知识和资源,
有效的机会,以推动该领域,促进公平的日益多样化的人口在
美国东南部,并为当地改善代谢健康的举措提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mohammed Kumail Ali其他文献
Mohammed Kumail Ali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mohammed Kumail Ali', 18)}}的其他基金
Training on ImplemenTAtioN and team Science for NCD Control (TITANS) program
非传染性疾病控制 (TITANS) 计划的实施和团队科学培训
- 批准号:
10665456 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Enhanced BReast and cErvical cAncer screening in Kenya THROUGH implementation science research and training (The BREAKTHROUGH Center)
通过实施科学研究和培训,肯尼亚加强了乳腺癌和宫颈癌筛查(突破中心)
- 批准号:
10738131 - 财政年份:2023
- 资助金额:
$ 11.9万 - 项目类别:
Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
- 批准号:
10528738 - 财政年份:2022
- 资助金额:
$ 11.9万 - 项目类别:
Can Medicaid Managed Care mitigate race/ethnic health disparities in diabetes?
医疗补助管理式医疗能否减轻糖尿病中的种族/民族健康差异?
- 批准号:
10709582 - 财政年份:2022
- 资助金额:
$ 11.9万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10508822 - 财政年份:2020
- 资助金额:
$ 11.9万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10841100 - 财政年份:2020
- 资助金额:
$ 11.9万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10705125 - 财政年份:2020
- 资助金额:
$ 11.9万 - 项目类别:
Integrating HIV and hEART health in South Africa (iHeart-SA)
在南非整合艾滋病毒和心脏抗逆转录病毒治疗 (iHeart-SA)
- 批准号:
10267701 - 财政年份:2020
- 资助金额:
$ 11.9万 - 项目类别: